GlassScriptPhysician profile
Mohammed Zaher
NPI 1538572862
$3,453.40
in general payments reported to CMS, 2019-2025
39 companies · $970 in 2025
The $970 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.19 · 2021: $462 · 2022: $312 · 2023: $885 · 2024: $809 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,418.72 |
| Education | $245.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $415.18 | 2021-2025 | Erleada |
| Teleflex LLC | $343.29 | 2021-2025 | Urolift, Barrigel |
| Merck Sharp & Dohme LLC | $324.66 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astellas Pharma US INC | $295.48 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $216.55 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $211.95 | 2022-2025 | |
| 180 Medical, INC. | $171.74 | 2023-2025 | Cure Catheter |
| Urogen Pharma, INC. | $116.94 | 2021-2025 | Jelmyto |
| Tolmar, INC. | $100.15 | 2023-2025 | Eligard, Jatenzo |
| Astrazeneca Pharmaceuticals LP | $98.01 | 2023-2025 | Lynparza |
| Vertex Pharmaceuticals Incorporated | $94.25 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $93.70 | 2021-2025 | Prolaris |
| Laborie Medical Technologies Corp. | $82.74 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $79.10 | 2023-2024 | |
| Axonics, INC. | $74.50 | 2023 | Axonics |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $73.78 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Telix Pharmaceuticals | $65.26 | 2025 | Illuccix |
| Endo Pharmaceuticals INC. | $53.52 | 2022-2023 | Xiaflex, Aveed |
| Boston Scientific Corporation | $47.85 | 2022-2023 | Rezum Generator |
| Sun Pharmaceutical Industries INC. | $45.02 | 2023-2025 | Yonsa |
| Novartis Pharmaceuticals Corporation | $44.51 | 2023 | |
| Progenics Pharmaceuticals, INC. | $40.70 | 2022-2025 | |
| Koelis INC. | $34.69 | 2023-2025 | |
| Ethicon US, LLC | $29.70 | 2024 | Echelon; Endopath, Echelon Endopath |
| Olympus America INC. | $28.59 | 2023-2025 | Itind System |
| Profound Medical Corp. | $26.56 | 2025 | Tulsa-Pro |
| Alexion Pharmaceuticals, INC. | $24.32 | 2023 | Ultomiris |
| Calyxo, INC. | $24.15 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $22.22 | 2023 | Aquabeam Robotic System |
| Srs Medical Systems, INC. | $21.56 | 2021 | |
| Genzyme Corporation | $20.15 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2022 | |
| Abbvie INC. | $18.51 | 2023 | Lupron Depot |
| Davol INC. | $17.79 | 2021 | |
| Intuitive Surgical, INC. | $17.76 | 2024 | |
| Medtronic, INC. | $17.65 | 2023 | Interstim |
| Neotract INC. | $15.19 | 2020 | |
| Myovant Sciences INC. | $13.53 | 2021 | |
| Halozyme INC | $13.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Zaher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.